COVID‐19 infection in an infant with cystic fibrosis: A case report and possible therapeutic effect of hypertonic saline

Pulmonary infections represent the major causes of morbidity and mortality in cystic fibrosis (CF). Here, we report a 3‐month‐old infant with pancreatic insufficient CF was hospitalized with positive RT‐PCR test for COVID‐19. He was treated successfully. Hypertonic saline can be hypothesized as a tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Seyedi, Seyed Javad, Sadeghi, Hossein, Kianifar, Hamid‐Reza, Hamedi, Abdolkarim, Saeidinia, Amin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9040559/
https://www.ncbi.nlm.nih.gov/pubmed/35498345
http://dx.doi.org/10.1002/ccr3.5782
_version_ 1784694362169409536
author Seyedi, Seyed Javad
Sadeghi, Hossein
Kianifar, Hamid‐Reza
Hamedi, Abdolkarim
Saeidinia, Amin
author_facet Seyedi, Seyed Javad
Sadeghi, Hossein
Kianifar, Hamid‐Reza
Hamedi, Abdolkarim
Saeidinia, Amin
author_sort Seyedi, Seyed Javad
collection PubMed
description Pulmonary infections represent the major causes of morbidity and mortality in cystic fibrosis (CF). Here, we report a 3‐month‐old infant with pancreatic insufficient CF was hospitalized with positive RT‐PCR test for COVID‐19. He was treated successfully. Hypertonic saline can be hypothesized as a treatment regimen against COVID‐19 infection after further investigations.
format Online
Article
Text
id pubmed-9040559
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-90405592022-04-28 COVID‐19 infection in an infant with cystic fibrosis: A case report and possible therapeutic effect of hypertonic saline Seyedi, Seyed Javad Sadeghi, Hossein Kianifar, Hamid‐Reza Hamedi, Abdolkarim Saeidinia, Amin Clin Case Rep Case Reports Pulmonary infections represent the major causes of morbidity and mortality in cystic fibrosis (CF). Here, we report a 3‐month‐old infant with pancreatic insufficient CF was hospitalized with positive RT‐PCR test for COVID‐19. He was treated successfully. Hypertonic saline can be hypothesized as a treatment regimen against COVID‐19 infection after further investigations. John Wiley and Sons Inc. 2022-04-26 /pmc/articles/PMC9040559/ /pubmed/35498345 http://dx.doi.org/10.1002/ccr3.5782 Text en © 2022 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Reports
Seyedi, Seyed Javad
Sadeghi, Hossein
Kianifar, Hamid‐Reza
Hamedi, Abdolkarim
Saeidinia, Amin
COVID‐19 infection in an infant with cystic fibrosis: A case report and possible therapeutic effect of hypertonic saline
title COVID‐19 infection in an infant with cystic fibrosis: A case report and possible therapeutic effect of hypertonic saline
title_full COVID‐19 infection in an infant with cystic fibrosis: A case report and possible therapeutic effect of hypertonic saline
title_fullStr COVID‐19 infection in an infant with cystic fibrosis: A case report and possible therapeutic effect of hypertonic saline
title_full_unstemmed COVID‐19 infection in an infant with cystic fibrosis: A case report and possible therapeutic effect of hypertonic saline
title_short COVID‐19 infection in an infant with cystic fibrosis: A case report and possible therapeutic effect of hypertonic saline
title_sort covid‐19 infection in an infant with cystic fibrosis: a case report and possible therapeutic effect of hypertonic saline
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9040559/
https://www.ncbi.nlm.nih.gov/pubmed/35498345
http://dx.doi.org/10.1002/ccr3.5782
work_keys_str_mv AT seyediseyedjavad covid19infectioninaninfantwithcysticfibrosisacasereportandpossibletherapeuticeffectofhypertonicsaline
AT sadeghihossein covid19infectioninaninfantwithcysticfibrosisacasereportandpossibletherapeuticeffectofhypertonicsaline
AT kianifarhamidreza covid19infectioninaninfantwithcysticfibrosisacasereportandpossibletherapeuticeffectofhypertonicsaline
AT hamediabdolkarim covid19infectioninaninfantwithcysticfibrosisacasereportandpossibletherapeuticeffectofhypertonicsaline
AT saeidiniaamin covid19infectioninaninfantwithcysticfibrosisacasereportandpossibletherapeuticeffectofhypertonicsaline

Ejemplares similares